Provided by Tiger Trade Technology Pte. Ltd.

Incyte

120.13
-1.2200-1.01%
Volume:119.87K
Turnover:14.45M
Market Cap:24.35B
PE:15.30
High:121.22
Open:121.05
Low:120.02
Close:121.35
52wk High:132.60
52wk Low:82.82
Shares:202.70M
Float Shares:169.82M
Volume Ratio:1.27
T/O Rate:0.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):7.85
EPS(LYR):6.41
ROE:30.67%
ROA:16.83%
PB:3.84
PE(LYR):18.74

Loading ...

Analysts Offer Insights on Healthcare Companies: Kuros Biosciences (OtherCSBTF), Centene (CNC) and Incyte (INCY)

TIPRANKS
·
Jul 29

Incyte : Guggenheim Raises Target Price to $150 from $136

THOMSON REUTERS
·
Jul 29

Incyte Corp. Stock Advances 9.3%, Outperforms Peers

Dow Jones
·
Jul 29

Incyte up over 10%, on Track for Highest Close Since September 2017

Dow Jones
·
Jul 29

Incyte Reports Strong Commercial Growth with 38% Revenue Surge and Upgraded Full-Year Forecast

Deep News
·
Jul 29

Incyte Says It's No Longer A One-Drug Story

Benzinga Earnings
·
Jul 29

Top Midday Gainers

MT Newswires Live
·
Jul 29

U.S. Stocks on the MOVE-Visa, CMS Energy, Ecolab

Reuters
·
Jul 29

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jul 29

Incyte price target raised to $145 from $123 at Stifel

TIPRANKS
·
Jul 29

Wells Fargo Adjusts Price Target on Incyte to $116 From $101

MT Newswires Live
·
Jul 29

Prelude Therapeutics rallies after Incyte prioritizes JAK2V617F pipeline

TIPRANKS
·
Jul 28

Movement Alert|Incyte Intraday Rise 5.24%, Q2 Earnings Significantly Beat Expectations with Full-Year Revenue Guidance Raised

Market Focus
·
Jul 28

Stock Track | Incyte Soars 5% in Intraday Trading on Q2 Earnings Beat and Raised Annual Revenue Guidance

Stock Track
·
Jul 28

Incyte Lifts Annual Revenue Forecast After Settlement with CMS

Reuters
·
Jul 28

Incyte Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 28

Kiniksa Pharmaceuticals Q2 Product Revenue Rises on Arcalyst Sales

Reuters
·
Jul 28

Incyte Q2 Non-GAAP Earnings, Revenue Rise; Raises 2026 Sales Guidance

MT Newswires Live
·
Jul 28

Incyte Q2 Adj. EPS $3.09 Beats $2.12 Estimate, Sales $1.663B Beat $1.460B Estimate

Benzinga Earnings
·
Jul 28

Incyte Q2 Adjusted EPS USD 3.09 Vs. IBES Estimate USD 2.1

Reuters
·
Jul 28